Concepedia

Mei Tang

MT

Statistics

Publications

11

Citations

505

H-Index

10

Active since

2006

Affiliations

Fred Hutch Cancer Center(Current)

Pfizer (United States)

Beijing Friendship Hospital

Astellas Pharma (United States)

Astellas Pharma (Japan)

Mei Tang is an author at Fred Hutch Cancer Center specializing in medicine, oncology, and breast cancer risk assessment.

Publications per year

2006–2024

11

Publications

11

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age

Christopher I. Li, Elisabeth F. Beaber, Mei Tang et al. · Breast Cancer Research and Treatment · 2012 · 145 citations · Full text

Medicine, Endocrinology, Oncology +13

<i>α</i> <sub>1</sub> -Antitrypsin Gene Therapy Modulates Cellular Immunity and Efficiently Prevents Type 1 Diabetes in Nonobese Diabetic Mice

Yuanqing Lu, Mei Tang, Clive Wasserfall et al. · Human Gene Therapy · 2006 · 81 citations

Medicine, Immunology, Molecular Medicine +14

Effect of Depo-Medroxyprogesterone Acetate on Breast Cancer Risk among Women 20 to 44 Years of Age

Christopher I. Li, Elisabeth F. Beaber, Mei Tang et al. · Cancer Research · 2012 · 76 citations · Full text

Medicine, Oncology, Preventive Medicine +13

Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts

Xianfei Zeng, H. Christina Fan, Dongxue Lu et al. · medRxiv · 2020 · 59 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +14

Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors

Mei Tang, Amit Garg, Peter L. Bonate et al. · Clinical Pharmacokinetics · 2024 · 39 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

1–5 of 11